Exane Derivatives’s iShares Biotechnology ETF IBB Stock Holding History

Exane Derivatives’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$149K	Buy	1,271 +454	+56%	+$53.9K	0.09%	209
2022 Q1	$106K	Hold	817	–	–	0.03%	466
2021 Q4	$125K	Sell	817 -20	-2%	-$3.1K	0.03%	416
2021 Q3	$135K	Buy	837 +60	+8%	+$10.1K	0.03%	485
2021 Q2	$125K	Hold	777	–	–	0.03%	514
2021 Q1	$117K	Sell	777 -48	-6%	-$7.62K	0.03%	400
2020 Q4	$125K	Sell	825 -176	-18%	-$25.2K	0.04%	368
2020 Q3	$136K	Buy	1,001 +940	+1,541%	+$128K	0.04%	250
2020 Q2	$8.34K	Hold	61	–	–	﹤0.01%	425
2020 Q1	$6.57K	Sell	61 -2,169	-97%	-$250K	﹤0.01%	442
2019 Q4	$271K	Hold	2,230	–	–	0.05%	219
2019 Q3	$222K	Hold	2,230	–	–	0.04%	237
2019 Q2	$243K	Hold	2,230	–	–	0.04%	242
2019 Q1	$249K	Hold	2,230	–	–	0.05%	202
2018 Q4	$215K	Sell	2,230 -1	-0%	-$106	0.04%	236
2018 Q3	$272K	Hold	2,231	–	–	0.05%	223
2018 Q2	$245K	Buy	2,231 +2,230	+223,000%	+$238K	0.04%	243
2018 Q1	$106	Sell	1 -455	-100%	-$50.4K	﹤0.01%	547
2017 Q4	$48.7K	Buy	456 +90	+25%	+$9.62K	0.01%	340
2017 Q3	$40.7K	Sell	366 -33	-8%	-$3.53K	0.01%	323
2017 Q2	$41.2K	Sell	399 -330	-45%	-$32.5K	0.01%	328
2017 Q1	$71.3K	Buy	729 +174	+31%	+$16.7K	0.02%	248
2016 Q4	$49.1K	Sell	555 -429	-44%	-$39K	0.01%	300
2016 Q3	$94.9K	Sell	984 -2,637	-73%	-$251K	0.01%	247
2016 Q2	$309K	Buy	+3,621	New	+$325K	0.05%	172

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Exane Derivatives's IBB Position: Q2 2022 in Review

Exane Derivatives increased its iShares Biotechnology ETF (IBB) stake by 56% in Q2 2022, buying an estimated $53.9K and bringing the position to 1,271 shares worth $149K. The position accounts for 0.09% of the portfolio, ranked #209.

Exane Derivatives first reported a position in IBB in Q2 2016 and has held it in 25 quarters since. The position peaked at $309K in Q2 2016. 859 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Exane Derivatives held 1,271 shares of iShares Biotechnology ETF worth $149K as of Q2 2022.
Exane Derivatives bought 454 iShares Biotechnology ETF shares in Q2 2022, an estimated $53.9K.
iShares Biotechnology ETF made up 0.09% of Exane Derivatives's portfolio in Q2 2022, its #209 holding.
Exane Derivatives first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 25 quarters since.
Exane Derivatives's iShares Biotechnology ETF position peaked at $309K in Q2 2016.
859 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.